The largest database of trusted experimental protocols

Egm 2 mv singlequot kit

Manufactured by Lonza

The EGM-2 MV SingleQuot Kit is a laboratory product designed to support the growth and maintenance of various cell types in cell culture. The kit contains a set of supplementary components that are added to a base medium to create a complete growth environment for cells. The core function of the kit is to provide the necessary nutrients, growth factors, and other additives required for optimal cell growth and proliferation.

Automatically generated - may contain errors

11 protocols using egm 2 mv singlequot kit

1

Cultivation of Endothelial and Fibroblast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lymphatic endothelial cells isolated from the lymph node (HLECs, 2500, ScienCell, Carlsbad, CA) and human umbilical vein endothelial cells (HUVECs, C2517A, Lonza, Allandale, NJ) were cultured separately in standard cell culture flasks coated with fibronectin (5μg/cm2, F1141-5MG, Sigma Aldrich, St. Louis, MO) at a starting cell concentration of 5 x 105 as per supplier instructions. Cultures were maintained with Endothelial Basal Medium-2 (EBM-2, CC-3156) supplemented with EGM-2 MV SingleQuot Kit (CC-4147, Lonza, Allandale, NJ). HLECs and HUVECs were cultured to 95% confluency at passages 4 and 5 for all experiments. Normal mammary fibroblasts (provided by Dr. Lisa Arendt’s lab at UW-Madison) and breast cancer-associated fibroblasts (provided by Dr. Andreas Friedl’s lab at UW-Madison) were cultured separately in standard flasks at a starting cell concentration of 5 x 105. Fibroblasts were maintained with Dulbecco’s Modified Eagle Medium (11965092, ThermoFisher Scientific, Waltham, MA) supplemented with 10% fetal bovine serum. All cultures were kept in a humidified incubator at 37 °C with 5% CO2.
+ Open protocol
+ Expand
2

Inflammatory Triggered EV Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC (BD Bioscience, cat # 354151) at passages three to six were seeded at a density of 600,000 cells in EBM-2 (Lonza) supplemented with EGM-2 MV SingleQuot Kit (Lonza) and 5% vesicles-depleted fetal bovine serum (System Bioscience). When HUVEC were grown up to 70–75% confluency, cells were washed twice with HEPES buffer saline (Lonza) and cells were then inflammatory triggered by adding 10 ng/ml TNF-α in refreshed medium for overnight (13 (link)). Afterward, the supernatants were collected for the EV isolation. All collected supernatant samples containing EV were stored at −80°C until EV isolation procedures.
THP-1 (ATCC® TIB-202™) were grown in RPMI-1640 (Life Technologies) medium supplemented with 10% vesicles-depleted fetal bovine serum (System Bioscience) and 1% penicillin–streptomycin–amphotericin B (Lonza Biowhittaker). All cell lines were incubated in a humidified atmosphere condition of 5% CO2/95% O2 at 37°C.
+ Open protocol
+ Expand
3

Co-culture of Lymphatic Endothelial Cells and Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lymphatic endothelial cells (HLECs, ScienCell, 2500) were cultured in standard cell culture flasks coated with fibronectin (5 µg/cm2, Sigma Aldrich, F1141–5MG) at a starting cell concentration of 5·105. Cultures were maintained with endothelial basal medium-2 (Lonza, CC-3156) supplemented with EGM-2 MV SingleQuot Kit (Lonza, CC-4147). HLECs were cultured to 90–95% confluency at passages 3 to 5 for all experiments and 3 different lots of lymphatic endothelial cells were used for the experiments. We used human mammary adenocarcinoma cells, MDA-MB-231, transfected to stably expressing green fluorescent protein (GFP), a kind gift from Dr. Suzanne Ponik (University of Wisconsin, Madison). MDA-MB-231s were routinely cultured in high glucose DMEM (Gibco, 11965092) supplemented with 10% fetal bovine serum (FBS, VWR, 97068–085) and 1% penicillin/streptomycin (ThermoFisher, 15140–122). For all experiments, a one to one mixture of lymphatic endothelial cell and MDA-MB-231 cell media was used (i.e., EGM-2 MV to 10% FBS, 1% P/S high glucose DMEM), called experimental media through the text. All cultures were kept in a humidified incubator at 37°C with 5% CO2.
+ Open protocol
+ Expand
4

Direct Reprogramming of Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human adult dermal fibroblasts (ATCC PCS-201-012) were purchased, mycoplasma-free and certified, directly from ATCC. No further cell line authentication/testing was conducted. The cells were expanded in fibroblast basal medium supplemented with fibroblast growth kit–serum-free (ATCC PCS 201–040) and penicillin/streptomycin. E12.5–E14 mouse embryonic fibroblasts (MEFs) were cultured in DMEM/F12 supplemented with 10% fetal bovine serum. Non-viral cell transfection and reprogramming experiments were conducted via three-dimensional nanochannel electroporation (NEP), as described previously11 (link). Briefly, the cells were first grown to full confluency overnight on the 3D NEP device. Subsequently, a pulsed electric field was used to deliver a cocktail of plasmids (0.05 μg μl−1) into the cells consisting of a 1:1:1 mixture of Fli1:Etv2:Foxc2. The cells were then collected 24 h after plasmid delivery, placed in EBM-2 basal medium (CC-3156, Lonza) supplemented with EGM-2 MV SingleQuot kit (CC-4147, Lonza) and further processed for additional experiments/measurements. Etv2 and Fli1 plasmids were donated by A. Ferdous (Department of Internal Medicine, UT Southwestern Medical Center, Texas). Foxc2 plasmids were donated by T. Kume (Department of Medicine–Cardiology and Pharmacology, Northwestern University–FCVRI, Chicago).
+ Open protocol
+ Expand
5

Acquisition and culture of endothelial and smooth muscle cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased pooled human umbilical vein endothelial cells (HUVEC; C2519A), human aortic endothelial cells (HAEC; CC-2535), and human coronary artery endothelial cells (HCAEC; CC-2585; Lonza) and cultured them in EBM-2 media supplemented with EGM-2 or EGM2-MV SingleQuot kit. We purchased immortalized HAEC (teloHAEC; CRL-4052; ATCC) and cultured them in vascular cell basal medium supplemented with vascular endothelial cell growth kit and puromycin at 0.3 μg/mL. Human coronary artery smooth muscle cells (HCASMC) and human aortic smooth muscle cells (HASMC) were obtained from Dr. Tardif’s lab and cultured in medium 231 (M-231-500) supplemented with smooth muscle growth supplement (S-007-25; Gibco). Monocytes were obtained from Dr. Rioux’s lab and we cultured them in RPMI with 10% fetal bovine serum. RNA from tissues was extracted either with the Ribopure Kit (Ambion) or using EZ1-XL Advance and Qiagen EZ1 RNA Tissue Mini Kit. hCA were obtained from the “Réseau d’Échanges de Tissus et d’Échantillons Biologiques” (RÉTEB) biorepository at the Montreal Heart Institute and Quebec Heart and Lung Institute. We purchased adult brain total RNA (540005–41, lot#6048990) and adult heart total RNA (540011–41, lot#6056165; Agilent Technologies).
+ Open protocol
+ Expand
6

HUVEC Culture and Inflammatory Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVEC (BD Bioscience, cat # 354,151) at passage 3–5 were grown in EBM-2 (Lonza) supplemented with EGM-2 MV SingleQuot Kit (Lonza; except the SingleQuot Kit foetal bovine serum) and 5% exosome-depleted foetal bovine serum (EXO-FBS-250A-1, System Bioscience) up to 70–75% confluency to minimize apoptosis. Confluent cells were rinsed twice with PBS (Lonza) and TNF-α (ImmunoTools, cat: 11,343,015)–based inflammation induction in cells was then performed at a final concentration of 10 ng/mL in a refreshed medium for 24 h [19 ]. Cells were incubated in a humidified atmosphere condition of 5% CO2/95% O2 at 37°C and routinely checked to be free of mycoplasma contamination.
+ Open protocol
+ Expand
7

Cell Culture Protocols for Cancer and Lymphatic Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7 (ATCC) and MDA-MB-231 (ATCC) cells were cultured in standard cell culture flasks and maintained in RPMI 1640 (BE12–702F, Lonza) supplemented with 10% FBS (97068–085, VWR). Human lymphatic endothelial cells (HLECs) isolated from the lymph node (2500, ScienCell) were cultured in standard cell culture flasks coated with fibronectin (5μg/cm2, F1141–5MG, Sigma Aldrich) at a starting cell concentration of 5 × 105 as per supplier instructions. HLECs were maintained with Endothelial Basal Medium-2 (CC-3156, Lonza) supplemented with EGM-2 MV SingleQuot Kit (CC-4147, Lonza) and used at 95% confluency at passages 3 and 4 for all experiments.
+ Open protocol
+ Expand
8

Nanoelectroporation of Dermal Cells for miRNA Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human adult dermal fibroblasts (ATCC, Manassas, VA, cat. no. PCS-201-012) were expanded in fibroblast basal medium (ATCC cat. no. PCS-201-030) supplemented with fibroblast growth kit-serum-free (ATCC, cat. no. PCS-201-040) containing Penicillin-Streptomycin (10,000 U/mL) solution (Gibco/Life Technologies, Waltham, MA, cat. no. 15140122) at 37 °C in humidified chamber consisting of 95% air and 5% CO2. Human dermal microvascular endothelial cells (HMECs)50 (link) were cultured in MCDB-131 medium (Gibco/Life Technologies, cat. no. 10372-019) supplemented with 10% FBS, 10 mM L-glutamine and 100 IU/mL penicillin and 0.1 mg/mL streptomycin.
In vitro nanoelectroporation was conducted via 3D Nanochannel Electroporation (NEP) as described previously51 (link). Briefly, the cells were first grown to full confluency overnight on the 3D NEP device. Subsequently, a pulsed electric field was used to deliver control or miR-200b inhibitor (50 nM) into the cells. The cells were then harvested 24 h after miRNA delivery, placed in EBM-2 basal medium (Lonza, cat. no. CC-3156) supplemented with EGM-2 MV SingleQuot kit components (Lonza, cat. no. CC-414 Supplementary 7) and processed further for additional experiments.
+ Open protocol
+ Expand
9

Culturing Human Lymphatic Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human lymphatic endothelial cells (HLECs, ScienCell, 2500) were cultured in standard T75 cm2 cell culture flasks (Corning, CLS430641U) coated with fibronectin as previously described [30 ,31 ] at a starting cell concentration of 5·105 cells. Cultures were maintained in endothelial basal medium-2 (Lonza, CC-3156) with EGM-2 MV SingleQuot Kit (Lonza, CC-4147), hereafter referred to as endothelial media. HLECs were cultured to 90-95% confluency at passage 3 for all experiments. Primary fibroblasts were routinely cultured in DMEM (Gibco, 11965092) with 10% fetal bovine serum (FBS, VWR, 97068-085), 1% Pen/Strep (ThermoFisher, 15140-122), and 1 µg/mL hydrocortisone (STEMCELL Technologies Inc., 07925). Primary human normal oral fibroblasts (HOrF, ScienCell, 2640) were cultured in standard T75 cm2 cell culture flasks (Corning, CLS430641U) at a starting cell concentration of 5·105 cells in fibroblast media (ScienCell, 2301). All cultures were kept in a humidified incubator at 37°C with 5% CO2. Media was refreshed every 2-3 days, and cells were cultured to 90-95% confluency.
+ Open protocol
+ Expand
10

Cell Culture Conditions for Cancer and Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
UM-SCC-1 and UM-SCC-6 cells were cultured with DMEM high glucose (Gibco, 11964-092) supplemented with Penicillin/Streptomycin (Gibco, 15140) and 10% FBS (VWR, Radnor). Human lymphatic endothelial cells (HLECs, ScienCell, 2500) were cultured with endothelial basal medium-2 (Lonza, CC-3156) supplemented with EGM-2 MV SingleQuot Kit (Lonza, CC-4147). Primary human normal oral fibroblasts (HOrFs, ScienCell, 2640) were cultured with fibroblast media (ScienCell, 2301). Cells were maintained at 37 C with 5% CO2 and media was refreshed every 2-3 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!